SCHEMBL22342893

SCHEMBL22342893

CNC(=O)c1cnn2c(NC)cc(Nc3cc(F)cc(F)c3OC)nc12

nearest known ligand 0.54

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ TYK2 P29597 19/20 0.54
▸ PDE4D Q08499 1/20 0.52
▸ STAT3 P40763 1/20 0.48
▸ JAK1 P23458 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22343247 0.92 TYK2 (0.54) TYK2PDE4D
SCHEMBL22342889 0.90 TYK2 (0.59) TYK2
SCHEMBL22343251 0.89 TYK2 (0.69) TYK2PDE4D
SCHEMBL22342894 0.88 TYK2 (0.69) TYK2
SCHEMBL22343246 0.87 TYK2 (0.49) TYK2PDE4DJAK1
SCHEMBL22323897 0.86 TYK2 (0.69) TYK2PDE4DJAK1
SCHEMBL23327706 0.86 TYK2 (0.44) TYK2PDE4D
SCHEMBL22343287 0.86 TYK2 (0.64) TYK2PDE4DJAK1
SCHEMBL21887349 0.80 TYK2 (0.69) TYK2PDE4DSTAT3JAK1
SCHEMBL23351157 0.80 TYK2 (0.42) TYK2PDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220135567-A1 TYK2 PSEUDOKINASE LIGANDS VENTYX BIOSCIENCES, INC. 2022-05-05 — — US disclosed
US-20220135567-A1 TYK2 PSEUDOKINASE LIGANDS VENTYX BIOSCIENCES, INC. 2022-05-05 — — US disclosed
WO-2020163778-A1 TYK2 PSEUDOKINASE LIGANDS VENTYX BIOSCIENCES, INC. (US) 2020-08-13 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220135567-A1 TYK2 PSEUDOKINASE LIGANDS TYK2, JAK2, PTK2B TYK2 1/4885PDE4D 4544/4885STAT3 76/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback